Quick Answer
Mirum Pharmaceuticals, Inc. reported Operating Income of -$22.14 million for fiscal year 2025.
Mirum Pharmaceuticals, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$22.14M | +74.7% |
| 2024 | -$87.61M | +19.7% |
| 2023 | -$109.15M | +16.8% |
| 2022 | -$131.22M | +24.3% |
| 2021 | -$173.41M | -66.3% |
| 2020 | -$104.30M | -90.5% |
| 2019 | -$54.74M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.60M | +120.5% | +152.2% |
| June 30, 2025 | -$4.99M | +79.4% | +67.1% |
| March 31, 2025 | -$15.18M | +42.6% | -19.7% |
| September 30, 2024 | -$12.68M | +49.6% | +47.7% |
| June 30, 2024 | -$24.23M | +0.2% | +8.4% |
| March 31, 2024 | -$26.47M | +2.5% | -5.2% |
| September 30, 2023 | -$25.15M | +23.5% | -3.6% |
| June 30, 2023 | -$24.27M | +22.8% | +10.6% |
- Mirum Pharmaceuticals, Inc. showed an increase of +74.7% in Operating Income compared to the prior fiscal year.
- Over the 2019–2025 period, Mirum Pharmaceuticals, Inc.’s operating income has grown by 59.6% (from -$54.74 million to -$22.14 million).
- The most recent figure is from Mirum Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: